This site is part of the Informa Connect Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 3099067.

PCC 2024 — Pharmaceutical Compliance Congress

NETWORKING BEGINS IN

  • 00
    Days
  • 00
    Hrs
  • 00
    Mins
  • 00
    Secs
Delivered as a Hybrid Event
April 16-18, 2024The Ritz-Carlton, Tysons Corner | McLean, VA

Jack Tanselle
Managing Director at Deloitte
Speaker

Profile

Jack has over 25 years of experience in the pharmaceutical, biotechnology, and medical device industries, ranging from product and therapeutic area strategic planning to enterprise risk management and compliance program effectiveness. Jack assists life sciences clients with compliance program development and transformations, focused on optimizing resources, leveraging the latest technology solutions (e.g., GenAI) and using fit-for-purpose analytics to help clients continuously identify and mitigate high risk activities and issues (e.g., anti-bribery and anti-corruption, off-label promotion, HCP engagement, patient services, transparency regulations).


Jack Tanselle's Network

Agenda Sessions

  • Strategies to Advance Auditing and Monitoring Programs

    3:30pm